Subcutaneous Heparin

DRUG4 trials

Conditions

Critical IllnessDeep Venous ThrombosisExtracorporeal Membrane Oxygenation ComplicationLymphocele After Surgical ProcedureProstate CancerPulmonary EmbolismSepsisVenous Thromboembolism

Phase 2

Anticoagulation-free VV ECMO for Acute Respiratory Failure

RecruitingNCT04273607

Damian RatanoExtracorporeal Membrane Oxygenation Complication

Start: 2022-09-01End: 2027-01-30Target: 40Updated: 2026-01-16

Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients

CompletedNCT04313790

Damanhour UniversityCritical Illness, Sepsis

Start: 2020-08-29End: 2022-10-11Updated: 2023-07-19

Phase 4

PREvention of VENous ThromboEmbolism Following Radical Prostatectomy

TerminatedNCT03006562

Johns Hopkins UniversityDeep Venous Thrombosis, Lymphocele After Surgical Procedure, Prostate Cancer +2

Start: 2017-07-01End: 2019-11-01Updated: 2020-08-05

Unknown Phase

Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients

WithdrawnNCT02707263

NYU Langone HealthVenous Thromboembolism

Start: 2016-03-31End: 2017-04-30Updated: 2017-04-27

Related Papers

Complications after open and robot‐assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trial

British Journal of Urology2020-07-1211 citations

MP04-10 COMPARISON OF OUTCOMES BETWEEN SINGLE-PORT AND STANDARD ROBOT-ASSISTED RADICAL PROSTATECTOMY AT A LARGE-VOLUME CENTER